|
|
||||||||
Radiology, Vol 160, 549-554, Copyright © 1986 by Radiological Society of North America
ARTICLES |
BM Romney, EL Nickoloff, PD Esser and PO Alderson
We determined a formula to establish objective guidelines for the administration of radionuclides to nursing mothers. The formula is based on the maximum permissible dose to the infant's critical organ, serial measurements of breast milk activity, milk volume, and dose to the critical organ per microcurie in milk. Using worst-case assumptions, we believe that cessation of nursing for 24 hours after administration of technetium labeled radiopharmaceuticals is sufficient for safety. Longer-lived agents require greater delays. Iodine-123 radiopharmaceuticals are preferable to iodine-131 agents and should always be used when studying the unblocked thyroid.
This article has been cited by other articles:
![]() |
A. F. Muller, H. A. Drexhage, and A. Berghout Postpartum Thyroiditis and Autoimmune Thyroiditis in Women of Childbearing Age: Recent Insights and Consequences for Antenatal and Postnatal Care Endocr. Rev., October 1, 2001; 22(5): 605 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Saenz Iodine-131 Elimination From Breast Milk: A Case Report J Hum Lact, February 1, 2000; 16(1): 44 - 46. [Abstract] [PDF] |
||||
![]() |
L. A. Herman and S. O'Neill Breastfeeding after Radionuclide Administration J Hum Lact, September 1, 1995; 11(3): 223 - 227. [PDF] |
||||
![]() |
B. Fulton and L. Moore Radiopharmaceuticals and Lactation J Hum Lact, December 1, 1990; 6(4): 181 - 184. [PDF] |
||||
![]() |
A. Jacobi From the Journals J Hum Lact, December 1, 1986; 2(3): 129 - 132. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |